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The predominant inhibitory transmitter, gamma-aminobutyric acid (GABA), and its 
GABAA receptors play an important role in the neuronal systems regulating sleep. In particular, 
the most effective hypnotics, benzodiazepines (BZ) and BZ-like compounds, target GABAA 
receptors. However, many hypnotics display side-effects. Therefore, there is a need to develop 
new compounds to treat insomnia. Interestingly, the effects of GABAA receptor agonists on sleep 
are substantially different from those evoked by BZ or BZ-like compounds. One of our aims is to 
decipher in mice the mechanisms underlying the specific effects of GABAA agonists, e.g. 
THIP/Gaboxadol and muscimol, on behavior and the electroencephalogram (EEG). 
Traditional hypnotics target synaptic GABAA receptors mediating “phasic” inhibition. 
We were able to demonstrate in vivo that THIP acts at extrasynaptic GABAA receptors mediating 
a non-desensitizing “tonic” inhibition in the brain. In addition, we demonstrated a relationship 
between regional electroencephalogram synchronization and the alteration of behavior induced by 
muscimol. Understanding the mechanisms underlying physiological and “pharmacological” sleep 
could provide a better basis to develop new compounds to treat sleep disorders, as well as to 
characterize their effects on the EEG and performance in human subjects. 
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